Showing results (1-10 of 155) with videos related to
Sort By:
Pageof 16
Journal of Medical Case Reports|September 17, 2017
Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case reportLinda Sakhri, Julian Pinsolle, Denis Moro-Sibilot, et al.Bulletin Du Cancer|August 7, 2016
[Not Available]Denis Moro-Sibilot, Léonie Ferrer, Matteo Giaj Levra, et al.Clinical Lung Cancer|July 15, 2011
Are clinical guidelines applied in routine daily practice?: a French regional survey of physicians' clinical practices in lung cancer management (EPOTRA)Sébastien Couraud, Pierre Fournel, Denis Moro-Sibilot, et al.Bulletin Du Cancer|March 28, 2025
[New perspectives in the management of small cell bronchial cancer]Elodie Berton, Camille Ardin, Giulia Berardi, et al.Bulletin Du Cancer|June 11, 2011
Professional practice and accessibility to equipment in thoracic oncology. Results of a survey in Rhônes-Alpes region (France)Sébastien Couraud, Pierre Fournel, Denis Moro-Sibilot, et al.Journal of Medical Case Reports|October 11, 2014
Atypical response to erlotinib in a patient with metastatic lung adenocarcinoma: a case reportLinda Sakhri, Elodie Meynet, Léonie Ferrer, et al.Cancers|November 3, 2020
Advances and Therapeutic Perspectives in Extended-Stage Small-Cell Lung CancerThomas Pierret, Anne-Claire Toffart, Matteo Giaj Levra, et al.Bulletin Du Cancer|June 14, 2020
[Immunotherapy of metastatic non-small cell lung cancer from first line to resistance and its management]Clémence Basse, Aurelie Swalduz, Matteo Giaj Levra, et al.BMC Medical Research Methodology|November 4, 2023
Comparison of seven comorbidity scores on four-month survival of lung cancer patientsHélène Pluchart, Sébastien Bailly, Sébastien Chanoine, et al.BMC Cancer|June 23, 2023
Impact of polypharmacy and comorbidity on survival and systemic parenteral treatment administration in a cohort of hospitalized lung-cancer patientsHélène Pluchart, Sébastien Bailly, Sébastien Chanoine, et al.Pageof 16